Skip to content

13F-HR filed by Clarius Group, LLC

Clarius Group, LLC filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-04-17, with 510 holding rows worth $1,177,693,978.

Accession
0001664214-23-000005
Filed
2023-04-17
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 510 entries on the cover page, a total value of $1,177,693,978 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,177,693,978 with VALUE read as dollars as filed, 13F file number 028-17249. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MIZUHO FINANCIAL GROUP INC SPONSORED ADR60687Y109ADR17,983$50,712dollars as filed
SYROS PHARMACEUTICALS INC87184Q206COM NEW18,620$49,715dollars as filed
VAXXINITY INC CLASS A92244V104COMMON STOCK20,000$45,400dollars as filed
LYELL IMMUNOPHARMA INC55083R104COM16,404$38,713dollars as filed
Skillsoft Corp.83066P200Common16,273$32,546dollars as filed
NUVATION BIO INC COM CL A67080N101Stock17,791$29,533dollars as filed
GINKGO BIOWORKS HOLDINGS INC37611X100CL A SHS17,761$23,622dollars as filed
OWLET INC69120X107COM41,198$13,365dollars as filed
F45 TRAINING HLDGS INC30322L101COM10,000$11,600dollars as filed
RUBIUS THERAPEUTICS INC78116T103COM21,393$456dollars as filedValue about 1/1,000 of the price other filers imply, kept as filed and left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001664214-23-000005this filing2023-04-17acceptance time not in the bulk data set